Groundbreaking Cancer Treatment Protocol Published: First-in-the-World Study on Ivermectin, Mebendazole, and Fenbendazole
Photo by Louis Reed on Unsplash
A revolutionary new study detailing a treatment protocol using Ivermectin, Mebendazole, and Fenbendazole for cancer has been peer-reviewed and published on September 19, 2024. The research introduces the mitochondrial-stem cell connection (MSCC) theory, positing that cancer originates from chronic oxidative phosphorylation (OxPhos) insufficiency in stem cells. This insufficiency can lead to the formation of cancer stem cells and abnormal energy metabolism, ultimately resulting in malignancy. For those interested in obtaining a copy of this groundbreaking study, please contact local physician Avery Brinkley Jr. MD, Panama City, FL through the Bay County Coastal. He can provide you with a copy of the study.
Dr. Peter McCullough, a leading cardiorenal physician based in Dallas, TX, commended the work of Drs. William Makis, Paul Marik, and their colleagues, highlighting the potential of repurposed, FDA-approved drugs with excellent safety profiles. He stated, "I believe that this study may open up an entirely new vista on our understanding of cancer and how to treat it."
Dr. McCullough emphasized the remarkable nature of the findings, noting the connection between the soil bacterium Streptomyces avermitilis, which produces a molecule that appears to suppress human cancer cell growth. "What a wondrous thing is nature!" he remarked.
The study integrates two well-established theories—the cancer stem cell theory and the metabolic theory—providing a fresh perspective on cancer treatment.
As this research unfolds, it may pave the way for innovative approaches to cancer therapy, potentially transforming treatment options for patients worldwide.
A healthy Bay County requires great community news.
Please support The Bay County Coastal, LLC by subscribing today!
Please support The Bay County Coastal, LLC by subscribing today!
You may also like: